Patients with end-stage renal disease should have arteriovenous fistula (AVF) formation 3 to 6 months prior to commencing hemodialysis (HD). However, this is not always possible with strained health care resources. We aim to compare autologous proximal AVF (PAVF) with distal AVF (DAVF) in patients already on HD. Primary end point is 4-year functional primary. Secondary end point is freedom from major adverse clinical events (MACEs). From January 2003 to June 2009, out of 495 AVF formations, 179 (36%) patients were already on HD. These patients had 200 AVF formations (49 DAVF vs 151 PAVF) in arms in which no previous fistula had been formed. No synthetic graft was used. Four-year primary functional patency significantly improved with PAVF (68.9% ± SD 8.8%) compared to DAVF (7.3% ± SD 4.9%; P < .0001). Five-year freedom from MACE was 85% with PAVF compared to 40% with DAVF (P < .005). Proximal AVF bestows long-term functional access with fewer complications compared to DAVF for patients already on HD.
BresciaMJCiminoJEAppelKHurwichBJ. Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. N Engl J Med. 1966;275(20):1089–1092.
2.
EthierJMendelssohnDCElderSJ. Vascular access use and outcomes: an international perspective from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant. 2008;23(10):3219–3226.
3.
ParlowAF.National Hormone Peptide Program—National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health: recombinant hormones, hypothalamic peptides other hormones, antisera, reagents, hormone assay services available. J Clin Endocrinol Metab. 2002;87(8):4026–4028.
4.
National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for 2006 Updates: Hemodialysis Adequacy, Peritoneal Dialysis Adequacy and Vascular Access. Am J Kidney Dis. 2006;48(suppl 1):S1–S322.
5.
SidawyANSpergelLMBesarabA. The Society for Vascular Surgery: clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access. J Vasc Surg. 2008;48(suppl 5):2S–25S.
6.
SidawyANGrayRBesarabA. Recommended standards for reports dealing with arteriovenous hemodialysis accesses. J Vasc Surg. 2002;35(3):603–610.
7.
RooijensPPTordoirJHStijnenTBurgmansJPSmet deAAYoTI. Radiocephalic wrist arteriovenous fistula for hemodialysis: meta-analysis indicates a high primary failure rate. Eur J Vasc Endovasc Surg. 2004;28(6):583–589.
8.
AllonMLockhartMELillyRZ. Effect of preoperative sonographic mapping on vascular access outcomes in hemodialysis patients. Kidney Int. 2001;60(5):2013–2020.
9.
SilvaMBJrHobsonRW2ndPappasPJ. A strategy for increasing use of autogenous hemodialysis access procedures: impact of preoperative noninvasive evaluation. J Vasc Surg. 1998;27(2):302–307.
10.
RobinsonBMPortFK. Caring for dialysis patients: international insights from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Identifying best practices and outcomes in the DOPPS. Semin Dial. 2010;23(1):4–6.
11.
PapanikolaouVPapagiannisAVrochidesD. The natural history of vascular access for hemodialysis: a single center study of 2,422 patients. Surgery. 2009;145(3):272–279.
12.
BonforteGRossiEAuricchioS. The middle-arm fistula as a valuable surgical approach in patients with end-stage renal disease. J Vasc Surg. 2010;52(6):1551–1556.
13.
AllonMRobbinML. Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions. Kidney Int. 2002;62(4):1109–1124.
14.
LinSLHuangCHChenHSHsuWAYenCJYenTS. Effects of age and diabetes on blood flow rate and primary outcome of newly created hemodialysis arteriovenous fistulas. Am J Nephrol. 1998;18(2):96–100.
15.
LeeHMannsBTaubK. Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis. 2002;40(3):611–622.
16.
PolkinghorneKRMcDonaldSPAtkinsRCKerrPG. Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol. 2004;15(2):477–486.
17.
BradburyBDFissellRBAlbertJM. Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol. 2007;2(1):89–99.
18.
DavisCFischerJLeyKSarembockIJ. The role of inflammation in vascular injury and repair. J Thromb Haemost. 2003;1(8):1699–1709.
19.
SiedleckiABarkerJAllonM. Aneurysm formation in arteriovenous grafts: associations and clinical significance. Semin Dial. 2007;20(1):73–77.
20.
JohanssonMMyredalAFribergPGanLM. High-resolution ultrasound showing increased intima and media thickness of the radial artery in patients with end-stage renal disease. Atherosclerosis. 2010;211(1):159–163.
21.
GolledgeJSmithCJEmeryJFarringtonKThompsonHH. Outcome of primary radiocephalic fistula for haemodialysis. Br J Surg. 1999;86(2):211–216.
22.
HakaimAGNalbandianMScottT. Superior maturation and patency of primary brachiocephalic and transposed basilic vein arteriovenous fistulae in patients with diabetes. J Vasc Surg. 1998;27(1):154–157.
23.
LazaridesMKGeorgiadisGSAntoniouGAStaramosDN. A meta-analysis of dialysis access outcome in elderly patients. J Vasc Surg. 2007;45(2):420–426.
24.
GrontoftKCLarssonRMulecHWeissLGDickinsonJP. Effects of ticlopidine in AV-fistula surgery in uremia. Fistula Study Group. Scand J Urol Nephrol. 1998;32(4):276–283.
25.
JanickiKDmoszynskaAJanickaLStettnerSJesipowiczJ.Influence of antiplatelet drugs on occlusion of arteriovenous fistula in uraemic patients. Int Urol Nephrol. 1992;24(1):83–89.
26.
SreedharaRHimmelfarbJLazarusJMHakimRM. Anti-platelet therapy in graft thrombosis: results of a prospective, randomized, double-blind study. Kidney Int. 1994;45(5):1477–1483.
27.
Roy-ChaudhuryPSukhatmeVPCheungAK.Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint. J Am Soc Nephrol. 2006;17(4):1112–1127.
28.
DemberLMBeckGJAllonM. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA. 2008;299(18):2164–2171.
29.
GhorbaniAAalamshahMShahbazianHEhsanpourAArefA. Randomized controlled trial of clopidogrel to prevent primary arteriovenous fistula failure in hemodialysis patients. Indian J Nephrol. 2009;19(2):57–61.
30.
HovensMMSnoepJDEikenboomJCvan der BomJGMertensBJHuismanMV. Prevalence of persistent platelet reactivity despite use of aspirin: a systematic review. Am Heart J. 2007;153(2):175–181.
31.
LauvaoLSIhnatDMGoshimaKRChavezLGruessnerACMillsJL, Sr. Vein diameter is the major predictor of fistula maturation. J Vasc Surg. 2009;49(6):1499–1504.
